Literature DB >> 19013427

Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts.

Kanako Kitahara1, Natsuko Kusunoki, Terutaka Kakiuchi, Toru Suguro, Shinichi Kawai.   

Abstract

The adipokines are linked not only to metabolic regulation, but also to immune responses. Adiponectin, but not leptin or resistin induced interleukin-8 production from rheumatoid synovial fibroblasts (RSF). The culture supernatant of RSF treated with adiponectin induced chemotaxis, although adiponectin itself had no such effect. Addition of antibody against adiponectin, and inhibition of adiponectin receptor gene decreased adiponectin-induced IL-8 production. Nuclear translocation of nuclear factor-kappa B was increased by adiponectin. The induction of interleukin-8 was inhibited by mitogen-activated protein kinase inhibitors. These findings suggest that adiponectin contributes to the pathogenesis of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013427     DOI: 10.1016/j.bbrc.2008.11.017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity.

Authors:  Y Zhang; M Peltonen; J C Andersson-Assarsson; P-A Svensson; C Herder; A Rudin; Lms Carlsson; C Maglio
Journal:  Scand J Rheumatol       Date:  2020-07-15       Impact factor: 3.641

Review 2.  Adipokines in bone disease.

Authors:  Elena Neumann; Susann Junker; Georg Schett; Klaus Frommer; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

3.  Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes.

Authors:  Zafar Rasheed; Nahid Akhtar; Tariq M Haqqi
Journal:  Rheumatology (Oxford)       Date:  2010-12-20       Impact factor: 7.580

Review 4.  What's new in our understanding of the role of adipokines in rheumatic diseases?

Authors:  Rodolfo Gómez; Javier Conde; Morena Scotece; Juan Jesus Gómez-Reino; Francisca Lago; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

Review 5.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

6.  [Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity].

Authors:  E A M Alkady; H M Ahmed; L Tag; M A Abdou
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

7.  Tacrolimus down-regulates chemokine expressions on rheumatoid synovial fibroblasts: screening by a DNA microarray.

Authors:  Kanako Kitahara; Natsuko Kusunoki; Hiroshi Takahashi; Kazuaki Tsuchiya; Shinichi Kawai
Journal:  Inflamm Res       Date:  2012-08-11       Impact factor: 4.575

8.  Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes.

Authors:  Yeon-Ah Lee; Hyun Mi Choi; Sang-Hoon Lee; Hyung-In Yang; Myung Chul Yoo; Seung-Jae Hong; Kyoung Soo Kim
Journal:  Exp Mol Med       Date:  2012-07-31       Impact factor: 8.718

9.  Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis : Impact on lipid status, glycoregulation, and risk for coronary heart disease.

Authors:  P Ostojic; D Bartolovic
Journal:  Z Rheumatol       Date:  2016-09       Impact factor: 1.372

Review 10.  Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.

Authors:  Morena Scotece; Javier Conde; Rodolfo Gómez; Verónica López; Jesús Pino; Antonio González; Francisca Lago; Juan J Gómez-Reino; Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2012-07-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.